Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Labeling of a mutant estrogen receptor with an Affimer in a breast cancer cell line
HTML
Details
Locations
Year:
2022
Type:
article
Source:
Biophysical Journal
DOI:
10.1016/j.bpj.2022.06.028
Authors:
Pin Ren,
Christian Tiede,
Sean W. Fanning,
Thomas Adams,
Valerie Speirs,
Erik R. Nelson,
Changfeng Cheng,
Terry W. Moore,
Geoffrey L. Greene,
Darren Tomlinson,
Paul R. Selvin
show all 11
Institutions:
University of Illinois Urbana-Champaign,
University of Leeds,
Loyola University Chicago,
University of Aberdeen,
University of Illinois Chicago,
Cancer Center at Illinois,
Carl R. Woese Institute for Genomic Biology,
University of Chicago
show all 8
Language:
English
Topic:
Estrogen and related hormone effects
Subfield:
Genetics
Field:
Biochemistry, Genetics and Molecular Biology
Domain:
Life Sciences
SDG:
Good health and well-being
Open Access status:
bronze
Funders:
National Science Foundation,
American Cancer Society,
National Sleep Foundation,
Breast Cancer Now,
Leverhulme Trust,
National Institutes of Health,
National Cancer Institute,
National Institute of General Medical Sciences,
National Institute of Neurological Disorders and Stroke
show all 9
Awards:
G1003277880,
G1864280218,
G3001750738,
Impact of cholesterol and its metabolites on breast cancer progression,
G4263525803,
G4300904254,
PFC: Center for the Physics of Living Cells,
Selective Antagonists of Mutant Estrogen Receptors,
G9000149474,
G9000254040
show all 10
OpenAlex ID:
W4283755757
FWCI:
0.269
Cites:
32
Cited by:
2
Related to:
10